HSPA5 and cancer: Due to YUM70’s ability to inhibit GRP78 with high specificity, induce apoptosis in cancer cells but not in normal cells (25), and reverse chemotherapy resistance, YUM70 holds great promise for future clinical development which includes further improvements in potency, safety and bioavailability.